Singapura - Inggeris - HSA (Health Sciences Authority)

ortho-clinical diagnostics singapore pte. ltd. - immunology - for the in vitro qualitative detection of hepatitis b surface antigen (hbsag) in human serum and plasma (edta, heparin or citrate). for in vitro use in the calibration of the vitros immunodiagnostic system for the qualitative detection of hepatitis b surface antigen (hbsag) in human serum and plasma (edta, heparin or citrate).

Singapura - Inggeris - HSA (Health Sciences Authority)

roche diagnostics asia pacific pte ltd - microbiology - immunoassay for the in vitro quantitative determination of hepatitis b surface antigen (hbsag) in confirmed hbsag positive human serum and plasma. the electrochemiluminescence immunoassay “eclia” is intended for use on cobas e immunoassay analyzers.

Singapura - Inggeris - HSA (Health Sciences Authority)

roche diagnostics asia pacific pte ltd - immunology - elecsys hbsag ii is an immunoassay for the in vitro qualitative determination of hepatitis b surface antigen (hbsag) in human serum and plasma. the electrochemiluminescence immunoassay "eclia" is intended for use on cobas e immunoassay analyzers. the performance has been established for diagnostic use and for screening of blood donations and for use of cadaveric blood specimens (plasma only).

Singapura - Inggeris - HSA (Health Sciences Authority)

siemens healthcare pte. ltd. - immunology - the advia centaur hbsag assay is an in vitro diagnostic immunoassay for the qualitative detection of hepatitis b surface antigen (hbsag) in human serum or plasma (edta, heparinized, citrate) using the advia centaur® system. the assay may be used in conjunction with other serological and clinical information to diagnose individuals with acute or chronic hepatitis b infection. the assay may also be used to screen for hepatitis b infection in pregnant women to identify neonates who are at risk of acquiring hepatitis b during the prenatal period.

Singapura - Inggeris - HSA (Health Sciences Authority)

siemens healthcare pte. ltd. - immunology - the advia centaur hbsag confirmatory assay is an in vitro diagnostic immunoassay for the qualitative confirmation of the presence of hepatitis b surface (hbsag) in human serum or plasma (edta, lithium or sodium heparn, citrate) using the advia centaur® system. the assay is intended to be used to confirm the presence of hbsag in samples that are repeatedly reactive using the advia centaur hbsag assay.

Singapura - Inggeris - HSA (Health Sciences Authority)

siemens healthcare pte. ltd. - immunology - the immulite hbsag confirmatory kit is intended for in vitro diagnostic use in conjunction with the immulite/immulite 1000 hbsag (lkhb) assay, immulite 2000 hbsag (l2khb) or the immulite 2500 hbsag (l5khb) assays — for confirming the presence of hepatitis b surface antigen (hbsag) in human serum or plasma which has tested reactive for hbsag by one of these assays.

Singapura - Inggeris - HSA (Health Sciences Authority)

siemens healthcare pte. ltd. - immunology - for in vitro diagnostic use with the immulite 2000 analyzer — for the qualitative detection of hepatitis b surface antigen (hbsag) in human serum or plasma (heparinized, sodium citrate or edta), as an aid in the determination of acute and chronic hepatitis b virus infections.

Singapura - Inggeris - HSA (Health Sciences Authority)

ortho-clinical diagnostics singapore pte. ltd. - microbiology - vitros immunodiagnostic products hbsag es reagent pack is for the qualitative detection of hepatitis b surface antigen (hbsag) in human serum and plasma (heparin). vitros immunodiagnostic products hbsag es calibrator is for use in the calibration of the vitros analyzers for the qualitative detection of hepatitis b surface antigen (hbsag) in human serum and plasma (heparin).

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

abbott australasia pty ltd diagnostic division - 48321 - hepatitis b virus surface antigen ivd, kit, chemiluminescent immunoassay - this assay is a one-step immunoassay for the qualitative detection of hbsag in human serum and plasma including specimens collected post mortem (non-heart-beating) using chemiluminescent microparticle immunoassay (cmia) technology, with flexible assay protocols, referred to as chemiflex. the hbsag next qualitative assay is a chemiluminescent microparticle immunoassay (cmia) for the qualitative detection of hepatitis b surface antigen (hbsag) in human serum and plasma including specimens collected post mortem (non-heart-beating) up to 24 hours after death on the architect isystem.

Singapura - Inggeris - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - immunology - the hbsag next confirmatory assay is a chemiluminescent microparticle immunoassay (cmia) for the confirmation of the presence of hepatitis b surface antigen (hbsag) in human serum and plasma including specimens collected post mortem (nonheart-beating) by means of specific antibody neutralization on the architect isystem. it is intended to be used for the confirmation of samples found to be repeatedly reactive by hbsag next qualitative.